MATTHEW KAHMANN: Open Payments
NPI 1245018985 · LIBERTY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 40 payments from 14 companies in 2025. Trend: 2023 $12 · 2024 $216 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 12 | $196 |
| Novartis Pharmaceuticals Corporation | 6 | $106 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| Amgen Inc. | 4 | $78 |
| Esperion Therapeutics, Inc. | 3 | $63 |
| Cleerly, Inc. | 1 | $61 |
| PFIZER INC. | 2 | $47 |
| Kestra Medical Technology Services, Inc. | 1 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: LifeVest, LEQVIO, VERQUVO, REPATHA, NEXLETOL, Cleerly Ischemia, Assure WCD, ELIQUIS.
Industry payments across MO — which companies pay providers there.
